Mrs. Emily A Olson, MS, CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 425 6th St, Reedsburg, WI 53959 Phone: 608-355-4200 |
Kelsey Ann Uhlenhake, MS, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 425 6th St, Reedsburg, WI 53959 Phone: 608-358-3633 |
Jennifer A Rathsack Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Sauk County Health Care Center, 1051 Clark Street, Reedsburg, WI 53959 Phone: 608-524-7500 |
Courtney Meulemans Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 N Dewey Ave, Reedsburg, WI 53959 Phone: 608-524-6487 |
Lydia Elizabeth Hunger, M.S., CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 425 6th St, Reedsburg, WI 53959 Phone: 608-963-8407 |
Kathryn Lauing Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1051 Clark St, Reedsburg, WI 53959 Phone: 608-524-7543 |
Jennifer Ashley Sweet, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1051 Clark St, Reedsburg, WI 53959 Phone: 608-524-7543 |
Sauk County Department Of Human Services Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 425 6th St, Reedsburg, WI 53959 Phone: 608-355-4200 |
Keely E. Bauer, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2357 Ernstmeyer Rd, Reedsburg, WI 53959 Phone: 608-415-0002 |
Mrs. Lorrie L Mittelstaedt, M.S., CCC-SLP, BCBA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 420 Viking Dr, Reedsburg, WI 53959 Phone: 608-524-9600 |
News Archive
Researchers at Case Western Reserve University School of Medicine have shown a high fat diet may lead to specific changes in gut bacteria that could fight harmful inflammation-a major discovery for patients suffering from Crohn's disease.
Lexicon Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, $95,000,000 of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Lexicon also intends to grant the underwriters a 30-day option to purchase up to an additional $14,250,000 of common stock to cover over-allotments, if any.
Tigris Pharmaceuticals, Inc., has announced that its Investigational New Drug (IND) application for the Company's geranylgeranyltransferase inhibitor (GGTI-2418) has been accepted by the U.S. Food and Drug Administration.
Some cases of recurrent pregnancy loss may be caused by sperm DNA damage in the male partner, rather than by a problem in affected women, according to research to be presented Sunday, March 24 at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.
People with type 2 diabetes are not consuming sufficiently healthy diets and could benefit from ongoing nutritional education and counseling, according to a new study by researchers at Wake Forest University School of Medicine and colleagues.
› Verified 1 days ago